REGENERON PHARMACEUTICALS, INC. (REGN) Stock buybacks 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$3.4BFY2025 · since FY2016: $0 → $3.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.4B | +32.1% |
| FY2024 | $2.6B | +16.5% |
| FY2023 | $2.2B | +7.3% |
| FY2022 | $2.1B | +26.6% |
| FY2021 | $1.6B | -71.9% |
| FY2020 | $5.8B | +2019.2% |
| FY2019 | $275.9M | +6170.5% |
| FY2018 | $4.4M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice